Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.13
+11.818.86%
Post-market: 145.840.7114+0.49%19:59 EDT
Volume:87.32M
Turnover:12.92B
Market Cap:57.94B
PE:-18.12
High:159.47
Open:133.11
Low:132.42
Close:133.32
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:1.40
T/O Rate:23.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.57
PE(LYR):-19.99

Loading ...

Barclays Sticks to Its Hold Rating for Moderna (MRNA)

TIPRANKS
·
Jun 22

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Reuters
·
Jun 22

Analysts Conflicted on These Healthcare Names: AbbVie (ABBV) and Moderna (MRNA)

TIPRANKS
·
Jun 22

Weekly Winners | WDC Soars 32%; MRNA Surges 28%; GEV Jumps 18%; HOOD Rallies 16%

Tiger Newspress
·
Jun 21

Under the Radar: Moderna Stock Rises on Flu-Shot Recommendation -- WSJ

Dow Jones
·
Jun 19

Moderna Reports Unanimous FDA Panel Backing for Flu Vaccine

MT Newswires Live
·
Jun 19

Moderna announces FDA advisory committee votes in favor of mRNA-1010

TIPRANKS
·
Jun 19

Moderna: FDA Prescription Drug User Fee Act (Pdufa) Goal Date Remains August 5, 2026

THOMSON REUTERS
·
Jun 19

Moderna Says FDA Advisory Committee Votes Unanimously in Favor of Benefit-Risk Profile of Mrna-1010, an Investigational Seasonal Influenza Vaccine

THOMSON REUTERS
·
Jun 19

Moderna up 4% after FDA advisers back flu vaccine approval

TIPRANKS
·
Jun 19

Market Chatter: Moderna's Flu Shot Wins Support From FDA Advisers

MT Newswires Live
·
Jun 19

Jefferies’ confidence in Moderna’s mRNA flu shot rises after AdCom support

TIPRANKS
·
Jun 19

FDA panel backs Moderna mRNA-based influenza vaccine, Bloomberg reports

TIPRANKS
·
Jun 19

US FDA Advisers Say Benefits of Moderna's Flu Vaccine Outweigh the Risks in Adults Aged 65 and Above

THOMSON REUTERS
·
Jun 19

Stock Track | Moderna Soars 8.85% in Early Trading on FDA Flu Vaccine Progress and Expansion Plans

Stock Track
·
Jun 18

Movement Alert|Moderna Rises 7.23% in Regular Trading, FDA Flu Vaccine Review Progress Combined with Capacity Expansion Plans

Market Focus
·
Jun 18

Moderna's mRNA flu vaccine faces FDA advisory panel scrutiny

Reuters
·
Jun 18

ETF Daily | EOSU Jumps 23%; MRNX Climbs 19%; ROBN, HODU Surge 18%; China Shorts and Gold Bears Outperform

ETF Tracker
·
Jun 18

Moderna President Stephen Hoge reports sale of 53,336 common shares valued at $2.74 million

Reuters
·
Jun 18

Sector Update: Healthcare Stocks Decline Wednesday Afternoon

MT Newswires Live
·
Jun 18